BJP College Seminars Series
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waddington, J. L.
Right arrow Articles by Youssef, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waddington, J. L.
Right arrow Articles by Youssef, H. A.

The British Journal of Psychiatry 153: 376-381 (1988)
© 1988 The Royal College of Psychiatrists

The expression of schizophrenia, affective disorder and vulnerability to tardive dyskinesia in an extensive pedigree

JL Waddington and HA Youssef
Royal College of Surgeons, St Stephen's Green, Dublin, Ireland.

The demography, psychiatric morbidity, and motor consequences of long- term neuroleptic treatment in the 14 children born to a father with a family history of chronic psychiatric illness and a mother with a late- onset affective disorder resulting in suicide are documented. Twelve siblings lived to adulthood, nine of whom were admitted to a psychiatric hospital in their second or third decade, and required continuous in-patient care; five remaining in hospital, with long-term exposure to neuroleptics, had chronic, deteriorating, schizophrenic illness and emergence of movement disorder. Two siblings showed no evidence of psychosis but developed a late-onset affective disorder. The implications for the issues of homotypia, vulnerability to involuntary movements, and interaction with affective disorder are discussed.


This article has been cited by other articles:


Home page
Schizophr BullHome page
M. J. Arranz and S. Kapur
Pharmacogenetics in Psychiatry: Are We Ready for Widespread Clinical Use?
Schizophr Bull, November 1, 2008; 34(6): 1130 - 1144.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1988 The Royal College of Psychiatrists.